Adalimumab/infliximabPainful cutaneous eruptions and alopecia: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1681卷 / 1期

关键词：

D O I：

10.1007/s40278-017-39293-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：17 / 17

相关论文

共 50 条

[31] Adalimumab/infliximabDevelopment of anti-drug antibodies: 7 case reports
Reactions Weekly, 2018, 1701 (1) : 15 - 15
[32] Adalimumab/ustekinumab/vedolizumabCOVID-19 infection: 7 case reports
Reactions Weekly, 2022, 1894 (1) : 22 - 22
[33] TelaprevirModerate cutaneous eruptions associated with HHV-6 reactivation: 2 case reports
Reactions Weekly, 2015, 1575 (1) : 198 - 198
[34] PiroxicamFixed drug eruptions and cross-reactivity to meloxicam: 7 case reports
Reactions Weekly, 2019, 1761 (1) : 306 - 306
[35] NSAIDs and paracetamolBullous fixed drug eruptions and drug misuse: 7 case reports
Reactions Weekly, 2023, 1985 (1) : 402 - 402
[36] TelaprevirSevere cutaneous eruptions: case report
Reactions Weekly, 2015, 1550 (1) : 193 - 193
[37] ImatinibLichenoid eruptions: 4 case reports
Reactions Weekly, 2006, 1114 (1) : 12 - 12
[38] MethotrexateSkin eruptions: 3 case reports
Reactions Weekly, 2009, 1254 (1) : 30 - 30
[39] DiphencyproneBullous eruptions, urticarial eruptions and vitiligo: 3 case reports
Reactions Weekly, 2014, 1495 (1) : 20 - 20
[40] PonatinibSkin eruptions: 5 case reports
Reactions Weekly, 2015, 1571 (1) : 196 - 196

← 1 2 3 4 5 →